Your browser doesn't support javascript.
loading
MRI Characteristics of Pediatric Renal Tumors: A SIOP-RTSG Radiology Panel Delphi Study.
van der Beek, Justine N; Watson, Tom A; Nievelstein, Rutger A J; Brisse, Hervé J; Morosi, Carlo; Lederman, Henrique M; Coma, Ana; Gavra, Maria M; Vult von Steyern, Kristina; Lakatos, Karoly; Breysem, Luc; Varga, Edit; Ducou Le Pointe, Hubert; Lequin, Maarten H; Schäfer, Jürgen F; Mentzel, Hans-Joachim; Hötker, Andreas M; Calareso, Giuseppina; Swinson, Sophie; Kyncl, Martin; Granata, Claudio; Aertsen, Michael; Di Paolo, Pier Luigi; de Krijger, Ronald R; Graf, Norbert; Olsen, Øystein E; Schenk, Jens-Peter; van den Heuvel-Eibrink, Marry M; Littooij, Annemieke S.
  • van der Beek JN; Department of Radiology and Nuclear Medicine, University Medical Center Utrecht/Wilhelmina Children's Hospital, Utrecht University, Utrecht, The Netherlands.
  • Watson TA; Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands.
  • Nievelstein RAJ; Department of Paediatric Radiology, Great Ormond Street Hospital NHS Foundation Trust, London, UK.
  • Brisse HJ; Department of Radiology and Nuclear Medicine, University Medical Center Utrecht/Wilhelmina Children's Hospital, Utrecht University, Utrecht, The Netherlands.
  • Morosi C; Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands.
  • Lederman HM; Imaging Department, Institut Curie, Paris, France.
  • Coma A; Department of Radiology, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy.
  • Gavra MM; Department of Diagnostic Imaging, Escola Paulista de Medicina, UNIFESP, São Paulo, Brazil.
  • Vult von Steyern K; Department of Pediatric Radiology, Hospital Vall d'Hebron, Barcelona, Spain.
  • Lakatos K; Department of Pediatric Radiology and Nuclear Medicine, 'Aghia Sophia' Children's Hospital, Athens, Greece.
  • Breysem L; Center for Medical Imaging and Physiology, Skåne University Hospital, Lund University, Lund, Sweden.
  • Varga E; Department of Radiology, St. Anna Children's Hospital, University Clinic of Pediatrics, Medical University of Vienna, Vienna, Austria.
  • Ducou Le Pointe H; Department of Radiology, University Hospitals Leuven, Leuven, Belgium.
  • Lequin MH; Department of Pediatrics, Semmelweis University, Budapest, Hungary.
  • Schäfer JF; Department of Pediatric Imaging, Hôpital d'Enfants Armand-Trousseau APHP, Paris, France.
  • Mentzel HJ; Department of Radiology and Nuclear Medicine, University Medical Center Utrecht/Wilhelmina Children's Hospital, Utrecht University, Utrecht, The Netherlands.
  • Hötker AM; Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands.
  • Calareso G; Division of Pediatric Radiology, Department of Radiology, University Hospital Tübingen, Tübingen, Germany.
  • Swinson S; Section of Pediatric Radiology, Institute of Diagnostic and Interventional Radiology, University Hospital Jena, Jena, Germany.
  • Kyncl M; Institute of Diagnostic and Interventional Radiology, University Hospital Zurich, Zurich, Switzerland.
  • Granata C; Radiology Unit, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy.
  • Aertsen M; Department of Paediatric Radiology, Leeds Teaching Hospitals, Leeds, UK.
  • Di Paolo PL; Department of Radiology, Second Faculty of Medicine, Charles University and University Hospital Motol, Prague, Czech Republic.
  • de Krijger RR; Department of Paediatric Radiology, Institute for Maternal and Child Health - IRCCS "Burlo Garofolo", Trieste, Italy.
  • Graf N; Department of Radiology, University Hospitals Leuven, Leuven, Belgium.
  • Olsen ØE; Department of Radiology, Bambino Gesù Children's Hospital, Rome, Italy.
  • Schenk JP; Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands.
  • van den Heuvel-Eibrink MM; Department of Pathology, University Medical Center Utrecht, Utrecht, The Netherlands.
  • Littooij AS; Department of Pediatric Oncology & Hematology, Saarland University Medical Center and Saarland University Faculty of Medicine, Homburg, Germany.
J Magn Reson Imaging ; 55(2): 543-552, 2022 02.
Article en En | MEDLINE | ID: mdl-34363274
ABSTRACT

BACKGROUND:

The SIOP-Renal Tumor Study Group (RTSG) does not advocate invasive procedures to determine histology before the start of therapy. This may induce misdiagnosis-based treatment initiation, but only for a relatively small percentage of approximately 10% of non-Wilms tumors (non-WTs). MRI could be useful for reducing misdiagnosis, but there is no global consensus on differentiating characteristics.

PURPOSE:

To identify MRI characteristics that may be used for discrimination of newly diagnosed pediatric renal tumors. STUDY TYPE Consensus process using a Delphi method. POPULATION Not applicable. FIELD STRENGTH/SEQUENCE Abdominal MRI including T1- and T2-weighted imaging, contrast-enhanced MRI, and diffusion-weighted imaging at 1.5 or 3 T. ASSESSMENT Twenty-three radiologists from the SIOP-RTSG radiology panel with ≥5 years of experience in MRI of pediatric renal tumors and/or who had assessed ≥50 MRI scans of pediatric renal tumors in the past 5 years identified potentially discriminatory characteristics in the first questionnaire. These characteristics were scored in the subsequent second round, consisting of 5-point Likert scales, ranking- and multiple choice questions. STATISTICAL TESTS The cut-off value for consensus and agreement among the majority was ≥75% and ≥60%, respectively, with a median of ≥4 on the Likert scale.

RESULTS:

Consensus on specific characteristics mainly concerned the discrimination between WTs and non-WTs, and WTs and nephrogenic rest(s) (NR)/nephroblastomatosis. The presence of bilateral lesions (75.0%) and NR/nephroblastomatosis (65.0%) were MRI characteristics indicated as specific for the diagnosis of a WT, and 91.3% of the participants agreed that MRI is useful to distinguish NR/nephroblastomatosis from WT. Furthermore, all participants agreed that age influenced their prediction in the discrimination of pediatric renal tumors. DATA

CONCLUSION:

Although the discrimination of pediatric renal tumors based on MRI remains challenging, this study identified some specific characteristics for tumor subtypes, based on the shared opinion of experts. These results may guide future validation studies and innovative efforts. LEVEL OF EVIDENCE 3 Technical Efficacy Stage 3.
Asunto(s)
Palabras clave

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Radiología / Tumor de Wilms / Neoplasias Renales Tipo de estudio: Prognostic_studies / Qualitative_research Límite: Humans Idioma: En Año: 2022 Tipo del documento: Article

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Radiología / Tumor de Wilms / Neoplasias Renales Tipo de estudio: Prognostic_studies / Qualitative_research Límite: Humans Idioma: En Año: 2022 Tipo del documento: Article